FDA Inspection
Catalent Pharma Solutions LimitedCatalent Pharma Solutions Limited – FDA Inspection, Jul 26, 2018
Record Details
This FDA Inspection record concerns Catalent Pharma Solutions Limited, with an inspection on July 26, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · e34de78c-e636-48d1-8b8a-9184de29130e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1064287
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
- Outcome
- Form 483 issued
Other FDA inspections of Catalent Pharma Solutions Limited
9| Date | Classification | Office | Project area |
|---|---|---|---|
| October 10, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 15, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 20, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 23, 2018 | Not classified | Office of Inspections and Investigations | |
| April 20, 2018 | VAI | Office of Inspections and Investigations | New Drug Evaluation |
Other documents for Catalent Pharma Solutions Limited
- FDA Inspection 1267053 - 2024-10-10
- FDA Inspection 1261182 - 2023-06-15
- FDA Inspection 1141164 - 2020-02-20
- FDA Inspection 1065786 - 2018-08-23
- FDA Inspection 1048918 - 2018-04-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.